Related Experiment Video
Updated: Jun 20, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
A multi-functional role of interferon regulatory factor-8 in solid tumor and myeloid cell biology
1Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. scott.abrams@roswellpark.org
Abstract:
Understanding mechanisms of tumor escape are critically important not only to improving our knowledge of cancer biology, but also for the overall development of more effective anti-neoplastic therapies. Our laboratory focuses on mechanisms of apoptotic resistance, with emphasis on Fas loss of function as an important determinant of tumor progression. Our work in solid tumor systems has led to the identification of interferon regulatory factor-8 (IRF-8) as a differentially expressed gene important for tumor cell response to cytotoxicity, including Fas-mediated apoptosis and host-anti-tumor immunosurveillance mechanisms. Although IRF-8 was originally identified in the regulation of normal and neoplastic myeloid cell development, these findings revealed a new functional role for IRF-8 in non-hematopoietic malignancies and establish a molecular basis for its potential manipulation during cancer therapy.
Insights
Interferon regulatory factor-8 (IRF-8) is crucial for tumor cells resisting apoptosis and immune surveillance. Targeting IRF-8 offers a new strategy for developing effective anti-cancer therapies against solid tumors.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- Tumor escape mechanisms are key to understanding cancer progression and developing therapies.
- Apoptotic resistance, particularly Fas loss of function, significantly impacts tumor development.
- Interferon regulatory factor-8 (IRF-8) is known for its role in myeloid cell development.
Purpose of the Study:
- To investigate the role of IRF-8 in tumor cell response to cytotoxicity.
- To explore IRF-8's function in solid tumor systems beyond its known role in myeloid cells.
- To identify novel molecular targets for anti-neoplastic therapies.
Main Methods:
- Analysis of IRF-8 expression in solid tumor models.
- Investigating the impact of IRF-8 on Fas-mediated apoptosis.
- Assessing IRF-8's role in host-anti-tumor immunosurveillance.
Main Results:
- IRF-8 is differentially expressed in solid tumors and influences tumor cell response to cytotoxicity.
- IRF-8 plays a significant role in Fas-mediated apoptosis resistance.
- IRF-8 impacts host-anti-tumor immune responses.
Conclusions:
- IRF-8 has a novel functional role in non-hematopoietic malignancies.
- IRF-8 is a critical determinant of tumor cell survival and immune evasion.
- IRF-8 represents a potential molecular target for enhancing cancer therapy efficacy.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Inhibitors of Viral Protein Synthesis
Regulation of Hematopoietic Stem Cells
Abnormal Proliferation
Master Transcription Regulators
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

